But as summer nears, health experts are warning against the consequences of excessive sun exposure. Here’s what t to know about skin cancer.
Author: Adrianna Rodriguez, USA TODAY
In ‘major breakthrough,’ new test can detect Parkinson’s disease before symptoms appear
A study sponsored by the Michael J. Fox Foundation finds a test of spinal fluid may be able to predict who is likely to develop Parkinson’s disease.
What does long COVID do to kids? What we’ve learned after a year of research.
We now know that between 5% to 10% of kids develop a wide range of health problems called post-COVID conditions or long COVID.
A dog died after getting bird flu in Canada. Here’s how to keep your pets safe.
Canadian health officials say the dog tested positive for bird flu on Saturday after chewing on a wild goose.
A ‘blueprint’ for longevity: New study has an answer for why some people live to be over 100
Scientists found people who live to be 100 or older – called centenarians – may have a unique immune profile that’s highly protective against disease.
Common cold viruses continue to rise heading into spring, CDC data shows. What to know.
Updated surveillance data from the Centers for Disease Control and Prevention show more cold viruses are being detected across the country.
The argument for making alcohol more expensive: It could save lives, study suggests.
The Scottish government made alcoholic drinks more expensive – and it saved people’s lives. Could this be implemented in the United States?
‘Urgent threat’: CDC warns against Candida auris, a drug-resistant fungus invading health care facilities
The CDC is calling Candida auris, a deadly fungal infection, an ‘urgent threat’ as screened cases have tripled from 2020 to 2021.
After years of medical progress, American children are now less likely to reach adulthood
Pediatric mortality increased by 20% between 2019 and 2021, the largest increase in 50 years. What can be done to protect children?
FDA approves nasal spray for migraines that may relieve symptoms within 30 minutes
A new nasal spray from Pfizer called Zavegepant promises to relieve migraine pain symptoms within 30 minutes.